BIODEXA PHARMACEUTICALS-ADR (BDRX)

US59564R7089 - ADR

4.4  +0.55 (+14.29%)

After market: 4.45 +0.05 (+1.14%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
578K
68.51%		699K
20.93%		381K
-45.49%		33.956K
-91.09%
EBITDA
YoY % growth
-6.595M
30.24%		-8.589M
-30.24%		-7.731M
9.99%		N/A
EBIT
YoY % growth
-6.998M
34.42%		-8.932M
-27.64%		-8.014M
10.28%		-12.995M
-62.15%
Operating Margin
-1,210.73%-1,277.83%-2,103.41%-38,269.48%
EPS
YoY % growth
N/AN/AN/A-3.92
80.32%

All data in GBP

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in GBP

Recent Earnings VS Estimates Surprises (GBP)
PeriodReportedEstimateDifferenceSurprise
Q2 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Recent Revenue VS Estimates Surprises (GBP)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 83K
-64.07%		%
Q2 2023
Q2Q % growth		 298K
-36.32%		%
Q4 2022
Q2Q % growth		 231K
30.51%		%
Q2 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q4 2020
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A -2400% -2400%
RevenueN/A N/A 0% 0%